Cafepharma Today

November 20 2024 - Novo, Viking heat up MASH space with promising data at AASLD24
Novo, Viking heat up MASH space with promising data at AASLD24
Pfizer, under pressure to change, names oncology head as new R&D chief
What might a Trump administration mean for the Biosecure Act?
Sage wilts as Huntington's prospect flunks trial
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

PTC's brain-delivered gene therapy gets US nod for rare genetic disorder
First Word Pharma
Thursday, November 14, 2024 - 9:59am
tags:
PTC Therapeutics, FDA, Kebilidi, AADC deficiency
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink
Fierce Pharma
Wednesday, November 13, 2024 - 9:49pm
tags:
M&A, Bristol Myers Squibb, Amgen, patent cliffs
Johnson & Johnson Takes the 340B Drug Rebate Fight to Federal Court
MedCity News
Wednesday, November 13, 2024 - 9:48pm
tags:
JNJ, 340B, legal, drug rebates
Gubra's weekly amylin obesity asset well-tolerated, tied to weight loss in phase 1 trial
Fierce Biotech
Wednesday, November 13, 2024 - 9:46pm
tags:
Gubra, obesity, GUBamy, clinical trials
[podcast]FDA's Foreign Inspections of Drug Manufacturers Have Not Rebounded to Pre-Pandemic Levels
GAO,gov
Wednesday, November 13, 2024 - 9:44pm
tags:
GAO, regulatory, foreign drug inspections, FDA
Marinus cuts 45% of staff after key medicine stumbled in pair of phase 3 trials
Fierce Pharma
Wednesday, November 13, 2024 - 7:29pm
tags:
Marinus Pharmaceuticals, layoffs, Ztalmy
BioNTech to buy Biotheus, gaining control of cancer bispecific
BioPharma Dive
Wednesday, November 13, 2024 - 11:30am
tags:
BioNTech, M&A, Biotheus, Summit Therapeutics, cancer bispecifics
Syros flunks phase 3 blood cancer trial, triggering loan default and share-price plunge
Fierce Biotech
Wednesday, November 13, 2024 - 11:29am
tags:
Syros Pharmaceuticals, clinical trials, tamibarotene
After election, FDA's Califf lays out hopes for his Trump-appointed successor
Fierce Pharma
Wednesday, November 13, 2024 - 11:22am
tags:
FDA, Robert Califf, regulatory
Fledgling Obesity Biotech Metsera Raises Another $215M for Long-Acting GLP-1
BioSpace
Wednesday, November 13, 2024 - 11:20am
tags:
Metsera, funding, obesity
Hidden data on obesity prospect wipe $12B off Amgen market cap
Fierce Biotech
Wednesday, November 13, 2024 - 11:10am
tags:
Amgen, MariTide, obesity, clinical trials
FDA hits Kezar's zetomipzomib program with 2nd clinical hold in 2 months
Fierce Biotech
Wednesday, November 13, 2024 - 11:09am
tags:
Kezar Life Sciences, FDA, zetomipzomib, clinical trials, autoimmune hepatitis
Japan's Otsuka Pharma & ICU Medical sign $200 M deal to create joint venture in North America for manufacturing IV solutions
BioSpectrum Asia
Wednesday, November 13, 2024 - 11:08am
tags:
Otsuka, ICU Medical, IVs
London "is number one European city in life sciences"
Pharmaphorum
Wednesday, November 13, 2024 - 10:57am
tags:
London, UK, Europe
Sanofi wins appeal in spat with NICE over Sarclisa
Pharmaphorum
Wednesday, November 13, 2024 - 10:53am
tags:
Sanofi, NHS, NICE, relapsed or refractory multiple myeloma, Sarclisa
Pharma’s grip on cancer R&D is having unintended consequences
Pharma Voice
Wednesday, November 13, 2024 - 10:52am
tags:
R&D, cancer, oncology
TRex Bio raises $84M to compete in crowded immune drug field
BioPharma Dive
Wednesday, November 13, 2024 - 10:51am
tags:
TRex Bio, funding, eczema
Merck, AstraZeneca report positive data for Koselugo in adults
MSN/Seeking Alpha
Tuesday, November 12, 2024 - 8:49pm
tags:
AstraZeneca, Merck, Koselugo, clinical trials, neurofibromatosis
GSK launches gynecological cancer initiative after survey reveals care gaps
Medical Marketing and Media
Tuesday, November 12, 2024 - 8:46pm
tags:
GSK, gynecological cancers, biomarkets
AstraZeneca, Daiichi withdraw lung cancer approval application for Enhertu follow-up and try again
Fierce Biotech
Tuesday, November 12, 2024 - 8:44pm
tags:
AstraZeneca, Daiichi Sankyo, lung cancer, FDA, Dato-DXd, Enhertu

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Down There in the Nano-Flow
In the Pipeline
Large Chains’ Position in 2025’s Part D Pharmacy Networks: Supermarkets Take the Lead in a Shrinking PDP Market
Drug Channels
CNS Drug Development: Same As It Ever Was
In the Pipeline
From Integration to AI: The Data-Driven Future of Market Access
Drug Channels
On RFK Jr. And What We're In For
In the Pipeline
Natural-Ish Product Motifs
In the Pipeline
Medicare Part D in 2025: Preferred Pharmacy Networks Fade in a Collapsing PDP Market
Drug Channels
Deuterium In Court
In the Pipeline
Drug Channels Outlook 2025 (NEW Live Video Webinar)
Drug Channels

Latest Jobs

Area Manager, Specialty Southeast
Fields, Oregon, 97710
CSL Behring
Neuroscience Account Manager - Milwaukee, WI
Milwaukee, Wisconsin, US
Lundbeck
BioPharmaceutical Account Manager - Houston South, TX
Houston, Texas, US
Lundbeck
Associate Director, Strategic Account Management -Pacific
San Francisco, California
AbbVie
Senior Director, US HIV Prevention Launch Hub Lead
Foster City, California
Gilead Sciences, Inc.
Therapy Development Manager Transcatheter Heart Valve
San Diego, California, 92189
Edwards Lifesciences
Neuroscience Account Manager (Psychiatry) - Missoula, MT
Missoula, Montana, 59812
Vanda Pharmaceuticals
Senior Account Manager IV Therapy - Northern CA / Nevada
Honolulu, Hawaii, 96814
Fresenius Kabi USA, LLC
Psychiatry Account Manager - Dayton West, OH
Oakwood, Ohio, 45873
Lundbeck
Neuroscience Account Manager (Psychiatry) - Detroit East, MI
Hamtramck, Michigan, 48212
Vanda Pharmaceuticals
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information